CY1121773T1 - Χρηση του παλμιτοϋλοαιθανολαμιδιου σε συνδυασμο με οπιοειδη - Google Patents
Χρηση του παλμιτοϋλοαιθανολαμιδιου σε συνδυασμο με οπιοειδηInfo
- Publication number
- CY1121773T1 CY1121773T1 CY20191100565T CY191100565T CY1121773T1 CY 1121773 T1 CY1121773 T1 CY 1121773T1 CY 20191100565 T CY20191100565 T CY 20191100565T CY 191100565 T CY191100565 T CY 191100565T CY 1121773 T1 CY1121773 T1 CY 1121773T1
- Authority
- CY
- Cyprus
- Prior art keywords
- combination
- opioids
- palmitoylethanolamide
- micronized form
- palmitoyl ethanolamide
- Prior art date
Links
- HXYVTAGFYLMHSO-UHFFFAOYSA-N palmitoyl ethanolamide Chemical compound CCCCCCCCCCCCCCCC(=O)NCCO HXYVTAGFYLMHSO-UHFFFAOYSA-N 0.000 title abstract 4
- 229950007031 palmidrol Drugs 0.000 title abstract 3
- 229940005483 opioid analgesics Drugs 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- HBMSIPLIFIVUKZ-UHFFFAOYSA-N Palmitinsaeure-propylamid Natural products CCCCCCCCCCCCCCCC(=O)NCCC HBMSIPLIFIVUKZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dispersion Chemistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI20140876 | 2014-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1121773T1 true CY1121773T1 (el) | 2020-07-31 |
Family
ID=51179022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191100565T CY1121773T1 (el) | 2014-05-14 | 2019-05-29 | Χρηση του παλμιτοϋλοαιθανολαμιδιου σε συνδυασμο με οπιοειδη |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9801836B2 (enExample) |
| EP (1) | EP2944309B1 (enExample) |
| JP (1) | JP6563685B2 (enExample) |
| KR (1) | KR102507891B1 (enExample) |
| CN (1) | CN105079811B (enExample) |
| AR (1) | AR100444A1 (enExample) |
| AU (1) | AU2015202575B9 (enExample) |
| BR (1) | BR102015011079A2 (enExample) |
| CA (1) | CA2891049C (enExample) |
| CY (1) | CY1121773T1 (enExample) |
| DK (1) | DK2944309T3 (enExample) |
| ES (1) | ES2731729T3 (enExample) |
| HU (1) | HUE044915T2 (enExample) |
| PL (1) | PL2944309T3 (enExample) |
| PT (1) | PT2944309T (enExample) |
| SM (1) | SMT201900345T1 (enExample) |
| TR (1) | TR201908936T4 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7244992B2 (ja) * | 2015-05-21 | 2023-03-23 | エスシーアイ スパーク リミティド | オピオイドとｎ－アシルエタノールアミンの組み合わせ |
| SG10201802129QA (en) | 2017-07-05 | 2019-02-27 | Frimline Private Ltd | A pharmaceutical composition for neuropathic pain |
| PH12018000227B1 (en) | 2017-09-05 | 2019-03-11 | Frimline Private Ltd | A pharmaceutical composition for improving or preventing progression of chronic kidney disease |
| WO2020141546A1 (en) * | 2019-01-02 | 2020-07-09 | Celagenex Research (India) Pvt. Ltd. | Synergistic nutritional compositions for pain management |
| EP4681710A1 (en) * | 2024-07-18 | 2026-01-21 | EPITECH GROUP S.p.A. | 2-pentadecyl-2-oxazoline as an opioid adjuvant to prevent or treat hyperalgesia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1271266B (it) | 1994-12-14 | 1997-05-27 | Valle Francesco Della | Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi |
| WO2001010434A1 (en) | 1999-08-06 | 2001-02-15 | Innovet Italia S.R.L. | Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field |
| DE60228713D1 (de) | 2001-07-18 | 2008-10-16 | Unilever Nv | Zusammensetzungen für die behandlung von haaren und/oder kopfhaut |
| US20050245557A1 (en) * | 2003-10-15 | 2005-11-03 | Pain Therapeutics, Inc. | Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain |
| CA2756178A1 (en) * | 2009-03-27 | 2010-09-30 | Abbott Laboratories | Compounds as cannabinoid receptor ligands |
| ES2548190T3 (es) * | 2009-09-07 | 2015-10-14 | Epitech Group S.P.A. | Composición que contiene palmitoiletanolamida ultramicronizada |
-
2015
- 2015-05-04 TR TR2019/08936T patent/TR201908936T4/tr unknown
- 2015-05-04 PT PT15166284T patent/PT2944309T/pt unknown
- 2015-05-04 HU HUE15166284 patent/HUE044915T2/hu unknown
- 2015-05-04 EP EP15166284.8A patent/EP2944309B1/en active Active
- 2015-05-04 PL PL15166284T patent/PL2944309T3/pl unknown
- 2015-05-04 ES ES15166284T patent/ES2731729T3/es active Active
- 2015-05-04 SM SM20190345T patent/SMT201900345T1/it unknown
- 2015-05-04 DK DK15166284.8T patent/DK2944309T3/da active
- 2015-05-12 CA CA2891049A patent/CA2891049C/en active Active
- 2015-05-13 AU AU2015202575A patent/AU2015202575B9/en active Active
- 2015-05-13 CN CN201510243856.6A patent/CN105079811B/zh active Active
- 2015-05-13 US US14/711,112 patent/US9801836B2/en active Active
- 2015-05-13 KR KR1020150066492A patent/KR102507891B1/ko active Active
- 2015-05-13 JP JP2015098334A patent/JP6563685B2/ja active Active
- 2015-05-14 BR BR102015011079A patent/BR102015011079A2/pt not_active IP Right Cessation
- 2015-05-14 AR ARP150101502A patent/AR100444A1/es unknown
-
2019
- 2019-05-29 CY CY20191100565T patent/CY1121773T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR102015011079A2 (pt) | 2016-03-29 |
| SMT201900345T1 (it) | 2019-07-11 |
| KR20150130931A (ko) | 2015-11-24 |
| JP6563685B2 (ja) | 2019-08-21 |
| PT2944309T (pt) | 2019-06-05 |
| ES2731729T3 (es) | 2019-11-18 |
| HUE044915T2 (hu) | 2019-11-28 |
| AR100444A1 (es) | 2016-10-05 |
| JP2015221794A (ja) | 2015-12-10 |
| EP2944309A1 (en) | 2015-11-18 |
| KR102507891B1 (ko) | 2023-03-08 |
| US9801836B2 (en) | 2017-10-31 |
| CN105079811B (zh) | 2020-06-23 |
| AU2015202575A1 (en) | 2015-12-03 |
| AU2015202575B2 (en) | 2020-03-05 |
| CA2891049A1 (en) | 2015-11-14 |
| US20150328173A1 (en) | 2015-11-19 |
| CA2891049C (en) | 2023-02-21 |
| CN105079811A (zh) | 2015-11-25 |
| TR201908936T4 (tr) | 2019-07-22 |
| DK2944309T3 (da) | 2019-06-03 |
| AU2015202575B9 (en) | 2020-03-26 |
| PL2944309T3 (pl) | 2019-09-30 |
| EP2944309B1 (en) | 2019-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124407T1 (el) | Ενωσεις αναστολεα αυτοταξινης | |
| CY1125068T1 (el) | Ενωσεις τετραϋποκατεστημενου αλκενιου και χρηση αυτων | |
| CY1123571T1 (el) | Βουπροπιονη για τη ρυθμιση των φαρμακευτικων επιπεδων δεξτρομεθορφανης στο πλασμα | |
| CY1121850T1 (el) | Διαρυλο μακροκυκλοι ως ρυθμιστες των πρωτεϊνικων kinασων | |
| CY1123595T1 (el) | Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5 | |
| CY1124436T1 (el) | Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια | |
| CY1123963T1 (el) | Καινοτομα πολυμερικα προφαρμακα hgh | |
| CY1123059T1 (el) | Αναστολη του διαυλου ιοντων παροδικου δυναμικου του υποδοχεα α1 | |
| CL2017001204A1 (es) | Derivados de 6-amino-7-biciclo-7-deaza-purina como inhibidores de la proteína quinasa | |
| CY1121930T1 (el) | Θεραπευτικοι παραγοντες για νευροεκφυλιστικες ασθενειες | |
| CY1120452T1 (el) | Παραγωγο αμιδιου πυραζολης | |
| CY1126036T1 (el) | Δοσολογικο σχημα σακουμπιτριλης-βαλσαρτανης για τη θεραπευτικη αντιμετωπιση της καρδιακης ανεπαρκειας | |
| EA201790180A1 (ru) | Способы и терапевтические комбинации для лечения опухолей | |
| CY1122899T1 (el) | Υδατικη συσταση περιλαμβανουσα παρακεταμολη και ιβουπροφαινη | |
| EA201692436A1 (ru) | Медицинское применение | |
| CY1123216T1 (el) | Αναστολεις της gls1 για την αντιμετωπιση νοσων | |
| EA201691481A1 (ru) | ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ | |
| CL2019001996A1 (es) | Usos terapéuticos de un polvo de insectos. | |
| CY1122968T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει μια ενωση διαμινο-ετεροκυκλικου καρβοξαμιδιου ως δραστικο συστατικο | |
| NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
| EA201791454A1 (ru) | Лекарственные формы для трансдермального введения | |
| DOP2016000170A (es) | Compuestos derivados de hidroxiformamida y usos del mismo | |
| MX2019001634A (es) | Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos. | |
| EA201691887A1 (ru) | Лечение внутрипеченочных холестатических заболеваний | |
| MD4710B1 (ro) | Tratamente terapeutice pe bază de anamorelin |